Streetbeat News

Analyst Ratings

BBIO

HC Wainwright & Co. has reiterated its Buy rating for BridgeBio Pharma, maintaining a price target of $43.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 10:48 am

OVID

HC Wainwright & Co. has reiterated its Buy rating for Ovid Therapeutics, maintaining a price target of $3. This suggests confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 10:42 am

BLFS

HC Wainwright & Co. has initiated coverage on BioLife Solutions (NASDAQ:BLFS) with a Buy rating and set a price target of $29.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 10:39 am

CLDX

Goldman Sachs has initiated coverage on Celldex Therapeutics with a Neutral rating and set a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 10:39 am

LEGN

HC Wainwright & Co. has reiterated its Buy rating on Legend Biotech, maintaining a price target of $73. This suggests confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 10:37 am

PR

Goldman Sachs has initiated coverage on Permian Resources with a Buy rating and set a price target of $19.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 10:33 am

NYXH

HC Wainwright & Co. analyst Edward White has reiterated a Buy rating on Nyxoah (NASDAQ:NYXH) and maintained a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 10:30 am

ZVRA

HC Wainwright & Co. analyst Oren Livnat has reiterated a Buy rating for Zevra Therapeutics (NASDAQ:ZVRA) and maintained a $20 price target.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 10:28 am

ALIT

Needham analyst Kyle Peterson has reiterated a Buy rating on Alight (NYSE:ALIT) and maintained a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 10:19 am

NAVI

B of A Securities has initiated coverage on Navient with a Neutral rating and set a price target of $17.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 10:17 am